Cargando…
Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.
The levels of deoxythymidine kinase in tumour cells (C-TK) and in serum (S-TK) were investigated and the tumour volume calculated in 89 patients with non-Hodgkin lymphoma (NHL), in order to ascertain the importance of C-TK and tumour burden as regards the S-TK levels. Among all patients, a correlati...
Autores principales: | Rehn, S., Gronowitz, J. S., Källander, C., Sundström, C., Glimelius, B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033808/ https://www.ncbi.nlm.nih.gov/pubmed/7734308 |
Ejemplares similares
-
The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
por: Gronowitz, J. S., et al.
Publicado: (1983) -
Serum thymidine kinase in acute leukaemia.
por: Hagberg, H., et al.
Publicado: (1984) -
2'-Deoxythymidine Adducts from the Anti-HIV Drug Nevirapine
por: Antunes, Alexandra M. M., et al.
Publicado: (2013) -
Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas.
por: Stokke, T., et al.
Publicado: (1998) -
Increased deoxythymidine triphosphate levels is a feature of relative cognitive decline
por: Desler, Claus, et al.
Publicado: (2015)